Steward Partners Investment Advisory, LLC Denali Therapeutics Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $11 Billion
- Q4 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 25 shares of DNLI stock, worth $534. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25Holding current value
$534% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DNLI
# of Institutions
245Shares Held
120MCall Options Held
91.1KPut Options Held
78.4K-
Black Rock Inc. New York, NY13.2MShares$282 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$263 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$257 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA9.85MShares$210 Million0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.48MShares$117 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.87B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...